The PPARα–leukotriene B4 pathway to inflammation control
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Inflammation is a local immune response to 'foreign' molecules, infection and injury. Leukotriene B4, a potent chemotactic agent that initiates, coordinates, sustains and amplifies the inflammatory response, is shown to be an activating ligand for the transcription factor PPARalpha. Because PPARalpha regulates the oxidative degradation of fatty acids and their derivatives, like this lipid mediator, a feedback mechanism is proposed that controls the duration of an inflammatory response and the clearance of leukotriene B4 in the liver. Thus PPARalpha offers a new route to the development of anti- or pro-inflammatory reagents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FFAs act as PPAR agonists facilitating translocation to the nucleus and dimerization to RXR [77,78].”
From Lipoprotein Lipase Regulates Microglial Lipid Droplet Accumulation (2021) · cites this paper as [77]
In the citing paper
“PPAR-α is involved in the regulation of pro-inflammatory genes, mainly by limiting cytokine expression.[109]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [109]
Citations
Cites
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Self-citationKliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., & Evans, R. M. (1992) · Nature · doi:10.1038/358771a0 · Cited by 1,741
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
Self-citation
Research works printed but not linked: 6
- Ford-Hutchinson, A. W. Crit. Rev. Immunol. 10, 1–11 (1990).
- Desvergne, B. & Wahli, W. in Inducible Transcription Vol. 1 (ed. Bæuerle, P.) 142–176 (Birkhäuser, Boston, 1995).
- Greene, M. E. et al. Gene Expr. 4, 281–299 (1995).
- Schmidt, A. et al. Mol. Endocrinol. 6, 1634–1641 (1992).
- Yu, K. et al. J. Biol. Chem. 270, 23975–23983 (1995). · DOI · Paper page
- Peters, J. M. et al. Mol. Pharmacol. 50, 67–94 (1996).
Cited by
Items 801–900 of 1,001
Role of peroxisome proliferator‐activated receptor‐α in acute pancreatitis induced by cerulein
Genovese, T., Mazzon, E., Paola, R. D., Muià, C., Crisafulli, C., Malleo, G., Esposito, E., & Cuzzocrea, S. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02393.x · Cited by 30
Effects of LTB4 receptor antagonism on pulmonary inflammation in rodents and non-human primates
Hicks, A., Goodnow, R. A., Cavallo, G., Tannu, S. A., Ventre, J. D., Lavelle, D., Lora, J. M., Satjawatcharaphong, J., Brovarney, M., Dabbagh, K., et al. (2010) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2010.02.003 · Cited by 29
Abdel-Razek, E. A.-N., Abo‐Youssef, A. M., & Azouz, A. A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117272 · Cited by 29
Cyclooxygenase isoforms and atherosclerosis
Belton, O., & Fitzgerald, D. J. (2003) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399403005842 · Cited by 31
Effects of soy protein on alcoholic liver disease in rats undergoing ethanol withdrawal
Yang, H., Lin, H.-S., Chao, J. C. ‐., Chien, Y., Peng, H.-C., & Chen, J. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.03.016 · Cited by 30
Promoter activity and regulation of the corneal CYP4B1 gene by hypoxia
Mastyugin, V., Mezentsev, A., Zhang, W., Ashkar, S., Dunn, M. W., & Schwartzman, M. L. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20018 · Cited by 29
“We have demonstrated that RCE cells do express transcripts forPPARaandPPARbbutnot forPPARg [Bonazzi et al., 2000].”
BackgroundMetabolism of arachidonic acid to eicosanoids within the nucleus
Luo, M., Flamand, N., & Brock, T. G. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.02.018 · Cited by 30
Bénani, A., Krémarik, P., Bianchi, A., Netter, P., Minn, A., & Dauça, M. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(02)00093-5 · Cited by 33
Cell surface receptors, nuclear receptors and ligands that regulate adipose tissue development
Ailhaud, G. P. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00100-x · Cited by 29
Peroxisome Proliferator-Activated Receptors
Heuvel, J. P. V., & Peters, J. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00209-8 · Cited by 30
Self-citationOxidative Stress and Peroxisome Proliferator–Activated Receptors: Reversing the Curse?
Devchand, P. R., Ziouzenkova, O., & Plutzky, J. (2004) · Circulation Research · doi:10.1161/01.res.0000151331.69399.b2 · Cited by 31
Self-citationBerry (2007) · doi:10.1155/2007/73256 · Cited by 28
“Thus, it was reported that PPARα can be activated by 8(S)-HETE and by leukotriene B4 (LTB4) [12, 13].”
BackgroundTherapeutic Use of Palmitoylethanolamide as an Anti-Inflammatory and Immunomodulator
de Sá, M. C. I., & Castor, M. G. M. E. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3040058 · Cited by 29
Naito, H., Yamanoshita, O., Kamijima, M., Katoh, T., Matsunaga, T., Lee, C., Kim, H., Aoyama, T., Gonzalez, F. J., & Nakajima, T. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000220565.90466.79 · Cited by 28
Self-citationLockyer, P. P., Schisler, J. C., Patterson, C., & Willis, M. S. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0374 · Cited by 33
Pereira, C., Mapuskar, K. A., & Rao, C. V. (2007) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2006.12.005 · Cited by 29
Mirshafiey, A., & Jadidi‐Niaragh, F. (2010) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903283662 · Cited by 30
Indapamide Lowers Blood Pressure by Increasing Production of Epoxyeicosatrienoic Acids in the Kidney
Ma, F., Lin, F., Chen, C., Cheng, J., Zeldin, D. C., Wang, Y., & Wang, D. W. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.085878 · Cited by 28
“PPARa activators are also highly expressed in the kidney (Braissant et al., 1996) and exert antioxidant and anti-inflammatory effects (Devchand et al., 1996; Diep et al., 2002; Kono et al., 2009).”
BackgroundInduction of Cytochrome P450 Enzymes
Williams, S. N., Dunham, E. E., & Bradfield, C. A. (2007) · Springer eBooks · doi:10.1007/0-387-27447-2_8 · Cited by 28
Elucidating cis- and trans-regulatory variation using genetical genomics
SLADEK, R. M., & Hudson, T. J. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.03.001 · Cited by 30
“determined by Mehrabian et al.’s study, LTB4 is a ligand of the transcription factor PPARa, which regulates the expression of many genes implicated in carbohydrate and fat metabolism [ 19 ].”
BackgroundLong chain fatty acids as modulators of gene transcription in preadipose cells
Grimaldi, P. A., Teboul, L., Gaillard, D., Armengod, A. V., & Amri, E. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4929-1_7 · Cited by 28
Maccarrone, M., Ranalli, M., Bellincampi, L., Salucci, M. L., Sabatini, S., Melino, G., & Finazzi‐Agrò, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2597 · Cited by 28
Bezafibrate for primary biliary cirrhosis
Rudić, J. S., Poropat, G., Krstic, M. N., Bjelaković, G., & Gluud, C. N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009145.pub2 · Cited by 35
Revermann, M., Mieth, A., Popescu, L. N., Paulke, A., Wurglics, M., Pellowska, M., Fischer, A., Steri, R., Maier, T., SCHERMULY, R. T., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01321.x · Cited by 30
“…mediators particularly the ability to activate peroxisome proliferator-activated receptors (PPARs) has been linked to anti-inflammatory actions (Devchand et al., 1996), and also for several drugs, a pleiotropic activation of PPARs has been shown to contribute to their anti-inflammatory effects…”
BackgroundYang, C.-C., & Yang, C. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s293135 · Cited by 28
“Among the PPARs, PPAR-α was the first shown to have a role in the control of inflammation.134 Devchand et al (1996) found that direct interaction between LTB4 and PPAR-α increased the catabolism of LTB4 and induced enzymes involved in fatty acid degradation, which further enhanced PPAR-α function…”
Barrera, G., Toaldo, C., Pizzimenti, S., Cerbone, A., Pettazzoni, P., Dianzani, M. U., & Ferretti, C. (2008) · PPAR Research · doi:10.1155/2008/524671 · Cited by 33
“PPAR agonists are not known to induce peroxisome proliferation in primates or humans, making the term PPARs archaic as well [5].”
BackgroundA mechanistic insight into 3,4-methylenedioxymethamphetamine (“ecstasy”)-mediated hepatotoxicity
Antolino-Lobo, I., Meulenbelt, J., van den Berg, M., & van Duursen, M. B. M. (2011) · Veterinary Quarterly · doi:10.1080/01652176.2011.642534 · Cited by 27
“Consequently, it down-regulates multiple pro-inflammatory mediators such as TNF- , IL-8, and iNOS (Devchand et al. 1996; Delerive et al. 2001; Ryoo et al. 2004; Straus and Glass 2007; Crisafulli and Cuzzocrea 2009; Yessoufou and Wahli 2010).”
BackgroundFidaleo, M., Arnauld, S., Clémencet, M.-C., Chevillard, G., Royer, M.-C., Bruycker, M. D., Wanders, R. J. A., Athias, A., Gresti, J., Clouet, P., et al. (2011) · Biochimie · doi:10.1016/j.biochi.2011.02.001 · Cited by 28
Nanoparticles prolong N-palmitoylethanolamide anti-inflammatory and analgesic effects in vivo
Tronino, D., Offerta, A., Ostacolo, C., Russo, R., Caro, C. D., Calignano, A., Puglia, C., & Blasi, P. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.01.058 · Cited by 28
Yang, M., Wang, Q., Wang, S., Wang, Y., Zeng, Q., & Qin, Q. (2018) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2018.09.003 · Cited by 27
“In endothelial cells and hepatocytes, levels of inflammatory targets, such as vascular cell adhesion molecule-1 and serum amyloid A, were increased in the absence of PPAR-α, and the response to inflammatory stimuli was prolonged (Devchand et al., 1996; Ziouzenkova et al., 2003; Han et al., 2006) .”
BackgroundTai, E. S., bin Ali, A., Zhang, Q., Loh, L. M., Tan, C. E., Retnam, L., Oakley, R. M. E., & Lim, S. K. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00578-7 · Cited by 27
PPARs in Alveolar Macrophage Biology
Smith, M. R., Standiford, T. J., & Reddy, R. C. (2007) · PPAR Research · doi:10.1155/2007/23812 · Cited by 30
“Copyright © 2007 Monica R. Smith et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.”
MethodShin, T. K., Yi, Y., Kim, J.-C., Pluske, J. R., Cho, H. M., Wickramasuriya, S. S., Kim, E., Lee, S. M., & Heo, J. M. (2017) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2017.04.022 · Cited by 31
“PGE2 is known to provoke anorexia and fever through stimulation of the neuroendocrine system (Rivest, 2010), while LTB4 controls the severity and duration of the inflammatory response (Devchand et al., 1996).”
BackgroundSheridan, R. M., Lampe, K., Shanmukhappa, S. K., Putnam, P., Keddache, M. A., Divanovic, S., Bezerra, J. A., & Hoebe, K. H. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021979 · Cited by 27
“). In the absence of functional Acox1, these lipid metabolites accumulate and act as natural ligands for the nuclear receptor PPARα”
BackgroundZhang, C., Song, Y., Yuan, M., Chen, L., Zhang, Q., Hu, J., Meng, Y., Li, S., Zheng, G., & Qiu, Z. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c05776 · Cited by 26
Yarchoan, M. M., Powderly, J. D., Bastos, B. R., Karasic, T. B., Crysler, O., Münster, P. N., McKean, M. A., Emens, L. A., Saenger, Y. M., Ged, Y. M. A., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0082 · Cited by 30
Zhang, Y., Chen, K., Dai, W., Xia, Y., Wang, F., Shen, M., Cheng, P., Wang, C., Yang, J., Zhu, R., et al. (2014) · Hepatology Research · doi:10.1111/hepr.12373 · Cited by 30
Dubrac, S., Elentner, A., Schoonjans, K., Auwerx, J. H., & Schmuth, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041357 · Cited by 26
Ye, N., Wang, H., Hong, J., Zhang, T., Lin, C., & Meng, C. (2015) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.077 · Cited by 28
“…activation of some other partners of RXRα also exhibited anti-inflammatory activity, such as liver X receptor, farnesoid X receptor, PPAR, RAR (Devchand et al., 1996; Muller and Bendtzen, 1996; Decula and Cantorna, 2001; Desreumaux et al., 2001; Sheu et al., 2002; Fowler et al., 2003; Liu et…”
BackgroundZhang, L., Ren, F., Zhang, X., Wang, X., Shi, H., Zhou, L., Zheng, S., Chen, Y., Chen, D., Li, L., et al. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.023242 · Cited by 26
“PPARα has been reported to regulate lipid metabolism (Staels et al., 1998), inflammation (Devchand et al., 1996; Delerive et al., 1999), cell differentiation and apoptosis (Roberts et al., 2002).”
BackgroundA New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma
Xu, Y., Li, X., Han, Y., Wang, Z., Han, C., Ruan, N., Li, J., Yu, X., Xia, Q., & Wu, G. (2020) · PPAR Research · doi:10.1155/2020/6937475 · Cited by 28
Bandeira‐Melo, C., Weller, P. F., & Bozza, P. T. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-950-5_10 · Cited by 27
Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation
Nicolete, R., Rius, C., Piqueras, L., Jose, P. J., Sorgi, C. A., Soares, E. G., Sanz, M., & Faccioli, L. H. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-36 · Cited by 26
Boie, Y., Stocco, R., Sawyer, N., Greig, G. M., Kargman, S., Slipetz, D. M., O’Neill, G. P., Shimizu, T., Yokomizo, T., Metters, K. M., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00514-2 · Cited by 26
Kasai, T., Miyauchi, K., Yokoyama, T., Aihara, K., & Daida, H. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.047 · Cited by 25
Emerging drugs for chronic obstructive pulmonary disease
Matera, M. G., Calzetta, L., Segreti, A., & Cazzola, M. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.660917 · Cited by 26
Routti, H., Berg, M. K., Lille‐Langøy, R., Øygarden, L., Harju, M., Dietz, R., Sonne, C., & Goksøyr, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-43337-w · Cited by 25
Scott, M. J., Cheadle, W. G., Hoth, J. J., Peyton, J. C., Subbarao, K., Shao, W.-H., & Haribabu, B. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.5.936-941.2004 · Cited by 25
Lin, J., Vambutas, A., Haruta, A., Paparella, M. M., Giebink, G. S., & Kim, Y. (1999) · The Journal of Infectious Diseases · doi:10.1086/314714 · Cited by 25
Neutrophils secrete exosome-associated DNA to resolve sterile acute inflammation
Arya, S. B., Collie, S. P., Xu, Y., Fernandez, M., Sexton, J. Z., Mosalaganti, S., Coulombe, P. A., & Parent, C. A. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01671-4 · Cited by 26
“It has been reported that high nanomolar concentrations of LTB 4 promote BLT1 endocytosis 84 and activate BLT2 and PPARα, both of which exert anti-inflammatory effects 18,33,34,85,86 .”
Zhang, Z., Su, H., Ahmed, R. Z., Zheng, Y., & Jin, X. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.114659 · Cited by 24
Peroxisome Proliferator‐Activated Receptors in HCV‐Related Infection
Dharancy, S., Lemoine, M., Mathurin, P., Serfaty, L., & Dubuquoy, L. (2009) · PPAR Research · doi:10.1155/2009/357204 · Cited by 24
“Animal studies confirmed the role of PPARα and PPARγ in inflammation control showing that PPARα−/− mice display a prolonged response to inflammation induced by arachidonic acid or zymosan [31–33].”
Targeting PPAR as a therapy to treat multiple sclerosis
Bright, J. J., Walline, C. C., Kanakasabai, S., & Chakraborty, S. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220802515400 · Cited by 26
“The expression of PPAR α in immune cells, development of an elevated immune response in PPAR α -deficient mice and the inhibition of inflammation by PPAR α agonists [51] suggested their use in the treatment of inflammatory diseases.”
MethodDose-dependent sub-chronic toxicity of diethyl phthalate in female Swiss mice
Mapuskar, K. A., Pereira, C., & Rao, C. V. (2006) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2006.07.005 · Cited by 25
Fatty acid signals in Bacillus megaterium are attenuated by cytochromeP-450-mediated hydroxylation
ENGLISH, N., PALMER, N. A. C., ALWORTH, L. W., Lan, K. A. N. G., Hughes, V. M., & Wolf, C. R. (1997) · Biochemical Journal · doi:10.1042/bj3270363 · Cited by 24
Atherosclerosis in type 2 diabetes: a role for fibrate therapy?
Steiner, G. A. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.067 · Cited by 25
Weindl, G., fer-Korting, M. S., Schaller, M., & Körting, H. C. (2005) · Drugs · doi:10.2165/00003495-200565140-00002 · Cited by 29
Leukotriene A4 Signaling, Inflammation, and Cancer
DuBois, R. N. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.14.1028 · Cited by 24
Nakagawa, K., Watanabe, K., Mizutani, K., Takeda, K., Takemura, S., Sakaniwa, E., Mikami, R., Kido, D., Saito, N., Kominato, H., et al. (2024) · Journal of Periodontal Research · doi:10.1111/jre.13249 · Cited by 24
Wilson, J. L. L., Duan, R., Elmarakby, A. A., Alhashim, A., & Lee, D. L. (2012) · PPAR Research · doi:10.1155/2012/645969 · Cited by 26
“[6] demonstrated that the absence of PPAR-α expression in mice prolonged the inflammatory responses, suggesting that PPAR-α has anti-inflammatory properties [7, 8].”
BackgroundIbarra-Lara, L., Sánchez-Aguilar, M., Soria‐Castro, E., Torres-Narváez, J. C., del Valle‐Mondragón, L., Cervantes-Pérez, L. G., Pérez‐Severiano, F., Ramírez-Ortega, M. D. C., Pastelín-Hernández, G. S., Oidor-Chan, V. H., et al. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0356 · Cited by 23
“Evidence was obtained from PPARα-/- mice, who exhibited a more intense and longer inflammatory process compared with wild type mice (Devchand et al. 1996).”
BackgroundAn insight to treat cardiovascular diseases through phytochemicals targeting PPAR-α
Sharma, S., Sharma, D., Dhobi, M., Wang, D., & Tewari, D. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04755-7 · Cited by 30
Bergamot Byproducts: A Sustainable Source to Counteract Inflammation
Russo, C., Lombardo, G. E., Bruschetta, G., Rapisarda, A., Maugeri, A., & Navarra, M. (2024) · Nutrients · doi:10.3390/nu16020259 · Cited by 25
“In the same context, the peroxisome proliferator-activated receptors (PPARs) have been shown to influence the gene expression of lipid mediators of inflammation, such as leukotrienes [30,31].”
BackgroundInnate immune system regulation of nuclear hormone receptors in metabolic diseases
Chow, E. K., Razani, B., & Cheng, G. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1206741 · Cited by 25
Vonghia, L., Herck, M. A. V., Weyler, J., & Francque, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00563 · Cited by 25
Structural insights on ligand recognition at the human leukotriene B4 receptor 1
Michaelian, N., Sadybekov, A., Besserer‐Offroy, É., Han, G. W., Krishnamurthy, H., Zamlynny, B., Fradera, X., Siliphaivanh, P., Presland, J. P., Spencer, K. B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23149-1 · Cited by 23
Chia, J. S. M., Farouk, A. A. O., Mohamad, T. A. S. T., Sulaiman, M. R., Zakaria, H., Hassan, N. I., & Perimal, E. K. (2021) · Molecules · doi:10.3390/molecules26133849 · Cited by 23
Ram, V. J. (2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8012-1_3 · Cited by 24
Jackson, I. L., Zhang, X., Hadley, C. C., Rabbani, Z. N., Zhang, Y., Marks, S., & Vujašković, Ž. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.04.014 · Cited by 24
Role of Peroxisome Proliferator-Activated Receptor α in Diabetic Nephropathy
Chung, S., & Park, C. W. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.4.327 · Cited by 25
Kane, C. D., Stevens, K. A., Fischer, J. E., Haghpassand, M., Royer, L. J., Aldinger, C. E., Landschulz, K. T., Zagouras, P., Bagley, S. W., Hada, W. A., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051656 · Cited by 23
“Studies using PPAR -null mice and potent inflammatory mediators such as LTB4 and LPS demonstrate that this nuclear receptor functions as a general modulator of the inflammatory response (Devchand et al., 1996; Delerive et al., 1999).”
MethodExpression and Catalytic Activity of Mouse Leukotriene B4 ω-Hydroxylase, CYP4F14
Kikuta, Y., Kasyu, H., Kusunose, E., & Kusunose, M. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2078 · Cited by 23
Thrombin induces endothelin expression in arterial smooth muscle cells
Lepailleur‐Enouf, D., Valdenaire, O., Philippe, M., Jandrot‐Perrus, M., & Michel, J. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.5.h1606 · Cited by 23
Mihalyi, A., Mutinda, K. C., Simsa, P., Debrock, S., Mwenda, J. M., & D’Hooghe, T. M. (2005) · Therapy · doi:10.2217/14750708.2.4.623 · Cited by 22
Chew, C.-H., Samian, M. R., Najimudin, N., & Muhammad, T. S. T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00731-9 · Cited by 22
The arachidonic acid–LTB4–BLT2 pathway enhances human B-CLL aggressiveness
Guriec, N., Jossic-Corcos, C. L., Simon, B., Ianotto, J., Tempescul, A., Dréano, Y., Salaün, J., Berthou, C., & Corcos, L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.07.016 · Cited by 24
Silva, J. C., Pitta, M. G. D. R., Pitta, I. D. R., Koh, T. J., & Abdalla, D. S. P. (2019) · Advances in Wound Care · doi:10.1089/wound.2018.0911 · Cited by 22
Tam, V. C., Suen, R., Treuting, P. M., Armando, A. M., Lucarelli, R., Gorrochótegui-Escalante, N., Diercks, A. H., Quehenberger, O., Dennis, E. A., Aderem, A. A., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006343117 · Cited by 26
Wang, J., Zhang, Q., Zhao, L., Li, D., Fu, Z., & Liang, L. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.071 · Cited by 23
Pescosolido, N., Librando, A., Puzzono, M., & Nebbioso, M. (2011) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2010.0191 · Cited by 23
Scholz‐Pedretti, K., Gans, A., Beck, K., Pfeilschifter, J. M., & Kaszkin, M. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133611 · Cited by 22
On the role of the peroxisome in the metabolism of drugs and xenobiotics
Masters, C. J. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00116-6 · Cited by 22
Down-regulation of vinculin upon MK886-induced apoptosis in LN18 glioblastoma cells.
Magro, A. M., Magro, A., Cunningham, C., & Miller, M. R. (2007) · PubMed · Cited by 21
Regulation of Wnt/β‐catenin pathway by cPLA 2 α and PPARδ
Han, C. L., Lim, K., Xu, L., Li, G., & Wu, T. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21852 · Cited by 21
“The transcription activity of PPARs is controlled by specific ligands (including AA derivatives) and co-activator or co-repressor proteins [Forman et al., 1995; Kliewer et al., 1995; Devchand et al., 1996].”
BackgroundRetractedRenga, B., D’Amore, C., Cipriani, S., Mencarelli, A., Carino, A., Sepe, V., Zampella, A., Distrutti, E., & Fiorucci, S. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.08.008 · Cited by 22
Rojas, C., Greiner, R. S., Fuenzalida, L. C., Martínez, J., Salem, N., & Uauy, R. D. (2002) · Lipids · doi:10.1007/s1145-002-0904-4 · Cited by 21
“Lately, it became apparent that PPAR not only participate in the regulation of FA oxidation and lipogenesis but also play a role in a wide array of cellular responses, including inflammation, thermogenesis, and cell differentiation (3, 11 ,12).”
BackgroundGreaves, P. (2007) · Elsevier eBooks · doi:10.1016/b978-044452771-4/50010-9 · Cited by 21
Molecular mechanisms of leukotriene synthesis: the changing paradigm
Peters-Golden, M. L. (1998) · Springer eBooks · doi:10.1007/978-94-011-4880-1_1 · Cited by 21
Rothberg, B. E. G., Sundseth, S. S., DiPippo, V. A., Brown, P. J., Winegar, D. A., Gottshalk, W. K., Shenoy, S. G., & Rothberg, J. M. (2001) · Functional & Integrative Genomics · doi:10.1007/s101420000022 · Cited by 21
“PPARα has been incriminated in immunomodulation, through increased hepatic clearance of inflammatory mediators such as leukotriene B4 ( Devchand et al. 1996 ) and through inhibition of interleukin-1-induced expression of interleukin-6 in a human aortic smooth muscle model (Staels et al. 1998).”
BackgroundKassam, A., Hunter, J., Rachubinski, R. A., & Capone, J. P. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00085-9 · Cited by 21
Vosper, H., Khoudoli, G. A., & Palmer, C. N. (2003) · Nuclear Receptor · doi:10.1186/1478-1336-1-9 · Cited by 22
Shinkai, Y., Sasaki, K., Tamura, R., Ike, T., Takahashi, A., Osaki, Y., Ishiuchi, N., Maeoka, Y., Nakashima, A., & Masaki, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-74340-5 · Cited by 23
Greger, D. L., Gropp, F., Morel, C., Sauter, S. N., & Blum, J. W. (2005) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2005.12.002 · Cited by 20
Attenuation of Acute Pancreatitis by Peroxisome Proliferator-Activated Receptor-α in Rats
Ding, J., Zhou, Z., Zhou, X., Zhou, B., Wang, L., Wang, R., Zhan, L., Sun, X., & Li, Y. (2012) · Pancreas · doi:10.1097/mpa.0b013e3182550cc4 · Cited by 20
Woods, C. G., Kosyk, O., Bradford, B. U., Ross, P. K., Burns, A., Cunningham, M. L., Qu, P., Ibrahim, J. G., & Rusyn, I. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.08.028 · Cited by 20
Knoch, B., Barnett, M. P. G., Cooney, J. M., McNabb, W. C., Barraclough, D., Laing, W. A., Zhu, S., Park, Z. A., Maclean, P. H., Knowles, S. O., et al. (2010) · PPAR Research · doi:10.1155/2010/621069 · Cited by 20
“[18] who observed a prolonged inflammatory response in Ppara−/− mice.”
BackgroundPrasad, G. S., Govardhan, P., Deepika, G., Vakdevi, V., & Sashidhar, R. B. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0428-y · Cited by 20
The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review
Davis, M. P., Behm, B., Mehta, Z. Y., & Fernandez, C. (2019) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909119850807 · Cited by 22
Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer
Cherkasova, V., Kovalchuk, O., & Kovalchuk, I. (2021) · Cancers · doi:10.3390/cancers13174353 · Cited by 20
Evidence for a pathophysiological role of cysteinyl leukotrienes in classical Hodgkin lymphoma
Schain, F., Tryselius, Y., Sjöberg, J., Porwit‐MacDonald, A., Backman, L., Malec, M., Xu, D., Vockerodt, M., Baumforth, K. R. N., Wei, W., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23781 · Cited by 20
Metadata
- Authors
- Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W.
- Affiliations
- University of Lausanne (CH)
- National Institutes of Health (US)
- Venue
- Nature
- Published
- 1996-11
- Volume
- 384
- Issue
- 6604
- Pages
- 39-43
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1671834350
- Cited by
- 1,345
- References
- 43
- Citations by year
- 2026: 3 · 2025: 17 · 2024: 14 · 2023: 21 · 2022: 9 · 2021: 38 · 2020: 30 · 2019: 23 · 2018: 21 · 2017: 24 · 2016: 23 · 2015: 22 · 2014: 43 · 2013: 34 · 2012: 49
- FWCI
- 28.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- PPARα, leukotriene B4, inflammation, transcription factor activation, fatty acid oxidation, lipid mediators, chemotaxis, anti-inflammatory agents, liver, feedback regulation
- MeSH terms
- Adaptation, Physiological, Animals, Cells, Cultured, Fatty Acids, Female, Gene Expression Regulation, HeLa Cells, Humans, Inflammation, Leukotriene B4, Ligands, Liver, Male, Oxidation-Reduction, Plasmids, Pyrimidines, Time Factors, Transcription Factors, Transfection, Chloramphenicol O-Acetyltransferase, Arachidonic Acid, Rats, Sprague-Dawley, Receptors, Cytoplasmic and Nuclear, Inflammation Mediators, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.